GSK Blasts Appeal Bid In Pa. Paxil Venue Dispute
GlaxoSmithKline LLC on Monday blasted a bid to have the Third Circuit decide whether the company could send a suit alleging antidepressant drug Paxil caused birth defects from state to federal...To view the full article, register now.
Already a subscriber? Click here to view full article